FPR Specialty Pharmacy Report issue

For profit Phase 3
Founded: Victor NY United States (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2014
NCT02068859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now